tiprankstipranks
Trending News
More News >
Munich Reinsurance (DE:MUV2)
:MUV2

Munich Reinsurance (MUV2) AI Stock Analysis

Compare
150 Followers

Top Page

DE

Munich Reinsurance

(LSE:MUV2)

Rating:70Neutral
Price Target:
€606.00
▲(8.64%Upside)
Munich Reinsurance's strong financial performance and attractive valuation contribute positively to its overall score. However, bearish technical indicators suggest cautious optimism is warranted. The absence of recent earnings call data and significant corporate events limits further insights.

Munich Reinsurance (MUV2) vs. iShares MSCI Germany ETF (EWG)

Munich Reinsurance Business Overview & Revenue Model

Company DescriptionMunich Reinsurance Company (MUV2), commonly known as Munich Re, is one of the world's leading reinsurance companies, based in Munich, Germany. The company operates through various segments, including reinsurance, primary insurance, and Munich Health. Munich Re provides comprehensive reinsurance solutions across various lines of business such as life, health, property, and casualty insurance. In addition to traditional reinsurance products, the company also offers risk management and advisory services, leveraging its extensive expertise and global network.
How the Company Makes MoneyMunich Re generates revenue primarily through its reinsurance business, where it underwrites insurance policies for other insurance companies, effectively spreading risk and providing financial protection. The company earns premiums from these reinsurance contracts, which form a significant portion of its income. Another revenue stream comes from its primary insurance segment, operated through its subsidiary ERGO Group, which sells a variety of insurance products directly to consumers. Additionally, Munich Re invests the premiums it collects in a diverse portfolio of assets, generating investment income that contributes significantly to its earnings. The company also engages in strategic partnerships and collaborations with other financial institutions and insurance entities to enhance its market reach and product offerings, further supporting its revenue streams.

Munich Reinsurance Financial Statement Overview

Summary
Munich Reinsurance demonstrates strong financial health with robust profitability and effective capital management. Revenue growth and margins are positive, but cash flow variability due to reduced cash reserves needs monitoring.
Income Statement
85
Very Positive
Munich Reinsurance exhibits strong financial performance with a consistent increase in net income and EBIT over the years. The gross profit margin is healthy due to the nature of the reinsurance industry. Recent revenue growth from 2023 to 2024 is 4.76%, and the net profit margin has improved, reflecting operational efficiencies. However, EBITDA margin data for 2024 is missing.
Balance Sheet
75
Positive
The balance sheet shows a stable financial position with a reasonable debt-to-equity ratio of 0.19 in 2024. The equity ratio is solid at 11.39%, indicating a strong equity base against total assets. Return on equity has improved to 17.41% in 2024, demonstrating effective use of shareholder funds. However, cash reserves have decreased from previous years, which might impact liquidity.
Cash Flow
70
Positive
Cash flow analysis shows a positive trend with a significant free cash flow increase of 28.68% from 2023 to 2024, indicating better cash generation capabilities. The operating cash flow to net income ratio is 0.55, suggesting good conversion of income into cash. However, the cash flow is subject to fluctuations in the investing and financing activities.
BreakdownDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue61.40B58.61B68.45B63.86B58.64B
Gross Profit61.40B64.73B68.45B63.86B58.64B
EBITDA7.97B5.52B7.06B3.81B1.98B
Net Income5.68B4.61B3.43B2.93B1.21B
Balance Sheet
Total Assets286.51B273.79B298.57B312.40B297.95B
Cash, Cash Equivalents and Short-Term Investments186.64B8.57B149.71B171.24B164.44B
Total Debt6.32B4.71B6.45B6.80B6.74B
Total Liabilities253.77B244.02B277.37B281.46B267.95B
Stockholders Equity32.64B29.65B21.06B30.83B29.89B
Cash Flow
Free Cash Flow2.83B2.20B-18.32B5.23B7.22B
Operating Cash Flow3.14B2.54B-7.64B5.23B7.22B
Investing Cash Flow-505.00M-329.00M11.35B-3.82B-6.13B
Financing Cash Flow-2.23B-2.98B-2.70B-1.68B-323.00M

Munich Reinsurance Technical Analysis

Technical Analysis Sentiment
Positive
Last Price557.80
Price Trends
50DMA
568.49
Negative
100DMA
556.56
Positive
200DMA
517.59
Positive
Market Momentum
MACD
-4.26
Negative
RSI
49.60
Neutral
STOCH
50.51
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For DE:MUV2, the sentiment is Positive. The current price of 557.8 is above the 20-day moving average (MA) of 555.36, below the 50-day MA of 568.49, and above the 200-day MA of 517.59, indicating a neutral trend. The MACD of -4.26 indicates Negative momentum. The RSI at 49.60 is Neutral, neither overbought nor oversold. The STOCH value of 50.51 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for DE:MUV2.

Munich Reinsurance Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
DETLX
76
Outperform
€28.10B13.9817.10%2.48%7.42%15.61%
DEDBK
74
Outperform
$47.65B10.746.68%2.39%3.36%3.08%
DECBK
74
Outperform
€33.28B11.969.28%2.31%17.06%25.66%
73
Outperform
€32.10B14.2619.63%3.38%9.68%18.57%
70
Neutral
€72.87B13.0418.25%3.11%6.63%26.20%
62
Neutral
AU$9.88B7.9410.79%5.20%32.02%38.31%
* Financial Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
DE:MUV2
Munich Reinsurance
557.80
113.96
25.68%
DE:HNR1
Hannover Rueck
266.20
34.09
14.69%
DE:DBK
Deutsche Bank AG
24.48
9.43
62.63%
DE:CBK
Commerzbank
28.09
13.70
95.21%
DE:TLX
Talanx AG
108.80
38.46
54.67%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jul 03, 2025